In the study by Parissis et al. (2005), soluble Fas (sFas) and soluble Fas Ligand (sFasL), markers of apoptosis were significantly reduced following GH therapy, suggesting an anti-apoptotic role in mitigating HF pathophysiology (p < 0.05) [22]. The gene discussed is GH1; the disease is hydrops fetalis.